{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:34:04Z","timestamp":1773484444172,"version":"3.50.1"},"reference-count":25,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human papillomavirus (HPV) infection is the most common sexually transmitted infection worldwide. Persistence infection can lead to the development of cervical cancer potentially due to some genetic factors such as polymorphisms in regulatory and coding regions of cytokine genes. The purpose of this study was to determine whether there is a relationship between TNF-308 G\/A or IL18 polymorphisms and high-risk HPV infection among sexually active women from Burkina Faso. Ninety-one HPV infected and two hundred and nine HPV negative women (the latter used as healthy controls) were screened. TNFA-308 G\/A and IL18-607 C\/A polymorphisms were detected using the TaqMan allelic discrimination. HPV 52 (21.19%), HPV 39 (11.86%) and HPV 33 (11.02%) were the most common HPV genotypes. The TNFA-308A and IL18-607 C alleles were predominant in all women in the study. None of the TNFA and IL18 alleles were associated with HPV infection. The results suggest that there is no relationship between TNF-308 G\/A or IL18-607C\/A polymorphisms and HPV infection among women in the study.<\/jats:p>","DOI":"10.1515\/bmc-2020-0008","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T07:43:26Z","timestamp":1588837406000},"page":"97-101","source":"Crossref","is-referenced-by-count":2,"title":["Association of TNF-\u03b1-308G\/A and IL-18 Polymorphisms with risk of HPV infection among sexually active women in Burkina Faso"],"prefix":"10.1515","volume":"11","author":[{"given":"Ina M. A.","family":"Traore","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Biology and Genetics (LABIOGENE), University Joseph KI-ZERBO , 03 BP 7021, Ouagadougou 03 , Ouagadougou Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th\u00e9odora M.","family":"Zohoncon","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology and Genetics (LABIOGENE), University Joseph KI-ZERBO , 03 BP 7021, Ouagadougou 03 , Ouagadougou Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florencia W.","family":"Djigma","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology and Genetics (LABIOGENE), University Joseph KI-ZERBO , 03 BP 7021, Ouagadougou 03 , Ouagadougou Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Rebeca","family":"Compaore","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology and Genetics (LABIOGENE), University Joseph KI-ZERBO , 03 BP 7021, Ouagadougou 03 , Ouagadougou Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Traore","sequence":"additional","affiliation":[{"name":"University Joseph KI-ZERBO , P.O. Box 7021 , Ouagadougou , Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Simpore","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology and Genetics (LABIOGENE), University Joseph KI-ZERBO , 03 BP 7021, Ouagadougou 03 , Ouagadougou Burkina Faso"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"2025120518281415169_j_bmc-2020-0008_ref_001_w2aab3b7c76b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394\u2013424.","DOI":"10.3322\/caac.21492"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_002_w2aab3b7c76b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003 Jan;16(1):1\u201317.","DOI":"10.1128\/CMR.16.1.1-17.2003"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_003_w2aab3b7c76b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Chinchai T, Homchan K, Sopipong W, Chansaenroj J, Swangvaree S, Junyangdikul P, et al. Lack of Associations between TNF-\u03b1Polymorphisms and Cervical Cancer in Thai women. Asian Pac J Cancer Prev. 2016;17(3):953\u20136.","DOI":"10.7314\/APJCP.2016.17.3.953"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_004_w2aab3b7c76b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford). 2010 Jul;49(7):1215\u201328.","DOI":"10.1093\/rheumatology\/keq031"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_005_w2aab3b7c76b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Rothe J, Lesslauer W, L\u00f6tscher H, Lang Y, Koebel P, K\u00f6ntgen F, et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 1993 Aug;364(6440):798\u2013802.","DOI":"10.1038\/364798a0"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_006_w2aab3b7c76b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Loetscher H, Stueber D, Banner D, Mackay F, Lesslauer W. Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors. J Biol Chem. 1993 Dec;268(35):26350\u20137.","DOI":"10.1016\/S0021-9258(19)74322-1"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_007_w2aab3b7c76b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Abe Y, Yamauchi K, Kimura S. 75- but not 55-kDa tumor necrosis factor receptor is active in the homotypic aggregation and proliferation of human lymphokine-activated T killer (T-LAK) cells in vitro. J Leukoc Biol. 1995 Mar;57(3):462\u20138.","DOI":"10.1002\/jlb.57.3.462"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_008_w2aab3b7c76b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 1995 Sep;377(6547):348\u201351.","DOI":"10.1038\/377348a0"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_009_w2aab3b7c76b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Kroeger KM, Carville KS, Abraham LJ. The \u2212308 tumor necrosis factor-\u03b1 promoter polymorphism effects transcription. Molecular Immunology. 4\/\/ 1997;34(5):391-399.","DOI":"10.1016\/S0161-5890(97)00052-7"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_010_w2aab3b7c76b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Elahi MM, Asotra K, Matata BM, Mastana SS. Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta. 2009 Mar;1792(3):163\u201372.","DOI":"10.1016\/j.bbadis.2009.01.007"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_011_w2aab3b7c76b1b6b1ab2b1c11Aa","unstructured":"Lebel-Binay S, Berger A, Zinzindohou\u00e9 F, Cugnenc P, Thiounn N, Fridman WH, et al. Interleukin-18: biological properties and clinical implications. Eur Cytokine Netw. 2000 Mar;11(1):15\u201326."},{"key":"2025120518281415169_j_bmc-2020-0008_ref_012_w2aab3b7c76b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest. 1998 Feb;101(3):711\u201321.","DOI":"10.1172\/JCI1379"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_013_w2aab3b7c76b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Piskin IE, Karakas-Celik S, Calik M, Abuhandan M, Kolsal E, Genc GC, et al. Association of interleukin 18, interleukin 2, and tumor necrosis factor polymorphisms with subacute sclerosing panencephalitis. DNA Cell Biol. 2013 Jun;32(6):336\u201340.","DOI":"10.1089\/dna.2013.1997"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_014_w2aab3b7c76b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Tavares MC, de Lima J\u00fanior SF, Coelho AV, Marques TR, de Ara\u00fajo DH, Her\u00e1clio SA, et al. Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion. Ann Hum Biol. 2016 May;43(3):261\u20138.","DOI":"10.3109\/03014460.2014.1001436"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_015_w2aab3b7c76b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Traore IM, Zohoncon TM, Dembele A, Djigma FW, Obiri-Yeboah D, Traore G, et al. Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso. BioMed Res Int. 2016;2016:7092583\u20137092583.","DOI":"10.1155\/2016\/7092583"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_016_w2aab3b7c76b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Traore IM, Zohoncon TM, Ndo O, Djigma FW, Obiri-Yeboah D, Compaore TR, et al. Oncogenic Human Papillomavirus Infection and Genotype Characterization among Women in Orodara, Western Burkina Faso. Pak J Biol Sci. 2016;19(7):306\u201311.","DOI":"10.3923\/pjbs.2016.306.311"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_017_w2aab3b7c76b1b6b1ab2b1c17Aa","unstructured":"Tjalma WA, Trinh XB, Rosenlund M, Makar AP, Kridelka F, Rosillon D, et al. A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in Belgium. Facts Views Vis Obgyn. 2015;7(2):101\u20138."},{"key":"2025120518281415169_j_bmc-2020-0008_ref_018_w2aab3b7c76b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, et al. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial. Gynecol Oncol. 2015 Apr;137(1):47\u201354.","DOI":"10.1016\/j.ygyno.2015.01.551"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_019_w2aab3b7c76b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Ouedraogo RA, Zohoncon TM, Guigma SP, Ang\u00e8le Traore IM, Ouattara AK, Ouedraogo M, et al. Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa. Papillomavirus Res. 2018 Dec;6:22\u20136.","DOI":"10.1016\/j.pvr.2018.09.001"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_020_w2aab3b7c76b1b6b1ab2b1c20Aa","unstructured":"Salambanga C, Zohoncon TM, Traor\u00e9 IM, Ouedraogo RA, Djigma WF, Ou\u00e9draog C, et al. Forte pr\u00e9valence de l\u2019infection au papillomavirus humain (HPV) \u00e0 haut risque chez les femmes sexuellement actives dans la ville de Ouagadougou, Burkina Faso. Med Sante Trop. 2019 Aug;29(3):302\u20135."},{"key":"2025120518281415169_j_bmc-2020-0008_ref_021_w2aab3b7c76b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Basile JR, Zacny V, M\u00fcnger K.The cytokines tumor necrosis factor-alpha (TNF-alpha) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein. 2001;276(25):22522-22528.","DOI":"10.1074\/jbc.M010505200"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_022_w2aab3b7c76b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Chagas BS, Lima RC, Paiva J\u00fanior SS, Silva RC, Cordeiro MN, Silva Neto JD, et al. Significant association between IL10-1082\/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus. Cytokine. 2019 Jan;113:99\u2013104.","DOI":"10.1016\/j.cyto.2018.06.014"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_023_w2aab3b7c76b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Stanczuk GA, Sibanda EN, Tswana SA, Bergstrom S. Polymorphism at the -308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer. Int J Gynecol Cancer. 2003 Mar-Apr;13(2):148\u201353.","DOI":"10.1046\/j.1525-1438.2003.13046.x"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_024_w2aab3b7c76b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Duarte I, Santos A, Sousa H, Catarino R, Pinto D, Matos A, et al. G-308A TNF-\u03b1 polymorphism is associated with an increased risk of invasive cervical cancer. Biochem Biophys Res Commun. 2005 Aug;334(2):588\u201392.","DOI":"10.1016\/j.bbrc.2005.06.137"},{"key":"2025120518281415169_j_bmc-2020-0008_ref_025_w2aab3b7c76b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Yang X, Qiu MT, Hu JW, Jiang F, Li M, Wang J, et al. Association of interleukin-18 gene promoter -607 C>A and -137G>C polymorphisms with cancer risk: a meta-analysis of 26 studies. PLoS One. 2013 Sep;8(9):e73671.","DOI":"10.1371\/journal.pone.0073671"}],"container-title":["Biomolecular Concepts"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/bmc\/11\/1\/article-p97.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/bmc-2020-0008\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/bmc-2020-0008\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T19:01:01Z","timestamp":1764961261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/bmc-2020-0008\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,4,15]]},"published-print":{"date-parts":[[2020,4,15]]}},"alternative-id":["10.1515\/bmc-2020-0008"],"URL":"https:\/\/doi.org\/10.1515\/bmc-2020-0008","relation":{},"ISSN":["1868-503X","1868-5021"],"issn-type":[{"value":"1868-503X","type":"electronic"},{"value":"1868-5021","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}